Choose the brand aligned with your industry so we can best serve your needs.
The Quidel™ Sofia™ 2 Analyzer and test kits use fluorescent immunoassay (FIA) to help you detect:
• Influenza A and B antigens from swab and wash samples (CLIA Waived)
• SARS-CoV-2 nucleocapsid protein antigens from swabs (CLIA Moderate)
• Lyme disease antibodies (human IgM and IgG to Borrelia burgdorferi, CLIA Moderate)
The Quidel™ Triage™ MeterPro combines sophisticated technology with user-friendly ergonomics to deliver high-performance testing in the laboratory or at the point of care.
Accelerate decision-making for cardiac conditions by quantitatively measuring levels of B-type natriuretic peptide or BNP in EDTA whole blood or plasma. Or qualitatively test for the presence of drugs or major metabolites of up to nine drug classes (amphetamines, barbiturates, benzodiazepines, cocaine, methadone, methamphetamine, opiates, THC, and tricyclic antidepressants).
The Quidel™ Solana™ platform makes molecular diagnostic testing faster and easier without sacrificing performance. Quidel’s proprietary methods (helicase-dependent amplification with fluorescence detection) deliver reliable Streptococcus, HSV, VZV, RSV, and hMPV results in less than an hour without the need for a thermal cycler.
The Quidel™ QuickVue™ line of products has been serving hospital and physician office labs for more than 30 years and continues to deliver quality results with a variety of formats well suited for both POC and laboratory needs. Count on QuickVue rapid lateral flow tests for quick, accurate results that allow for faster diagnosis and treatment.
Quidel™ Lyra™ real-time PCR assays enable high-throughput molecular testing for identifying infectious diseases. Easy to use involving only a few steps and easily storable under refrigeration, Lyra assays can help you expand your offering and bring tests in house. They have been validated on popular equipment, including Applied Biosystems™ 7500 Fast Dx Real-Time PCR, Cepheid™ SmartCycler™ II, and Life Technologies QuantStudio™ Dx Real-Time PCR Instruments. For added simplicity, Lyra Direct Molecular Assays require no RNA/DNA purification.
Quidel Lyra SARS-CoV-2 Molecular Assay
Quidel Lyra Direct SARS-CoV-2 Molecular Assay
Quidel Lyra Influenza A+B Molecular Assay
Quidel Lyra Parainfluenza Molecular Assay
Quidel Lyra Adenovirus Molecular Assay
Quidel Lyra RSV+hMPV Molecular Assay
Quidel Lyra Direct Strep Molecular Assay
Uses a monoclonal antibody specific to the beta subunit of hCG in a single-step technology
For use with Quidel QuickVue Flex Strep A and QuickVue In-Line™ One-Step Strep A Tests
Kinetic Check™ feature provides operator the flexibility of upto 5 minutes before placing test cassette into Sofia for analysis
Features rapid method of nucleic acid amplification that does not require thermal cycler. For qualitative detection of Group A β-hemolytic Streptococcus (Streptococcus pyogenes), and pyogenic Group C/G (streptococcus dysgalactiae) nucleic acids.
Clia Complexity | Moderate |
---|
Detects SARS-CoV-2 antigens directly from anterior nares swab specimens. The QuickVue SARS Antigen Test provides accurate and reliable results in 10 minutes.
For rapid differential diagnosis of acute influenza A and influenza B viral infections.
Specificity | 95.1.% / 99.3% (culture) 96.8%/98.9% (PCR) |
---|---|
Sensitivity | 98.6.%/100.0% (Culture), 97.2%/100% (PCR) |
Content And Storage | 2°C to 8°C |
Control Sets | M106 |
Detectable Analytes | Influenza A and B |
Shelf Life | 12 Months from DOM |
CE Marker | Yes |
CPT Code | 87502 |
Clia Complexity | Moderate |
Test Time | ≈45 min. |
in vitro diagnostic test for the qualitative detection of Group A β-hemolytic Streptococcus (Streptococcus pyogenes) nucleic acids. The Solana GAS Assay is for use with samples isolated from throat swab specimens from patients with signs and symptoms of pharyngitis, such as sore throat.
To be used as full process controls in molecular testing
Uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from influenza A and influenza B, and SARS-CoV-2. Allows for testing of patients suspected of influenza A, influenza B, and COVID-19/2019-nCoV at the Point of Care.
Unique patented in-line extraction method reduces hands-on time and provides quick results
Quidel™ Solana HSV 1+2/VZV Assay is multiplex in vitro diagnostic test for detection and differentiation of Herpes simplex virus type 1 (HSV-1), Herpes simplex virus type 2 (HSV-2), and Varicella-zoster virus (VZV) nucleic acids isolated and purified from cutaneous or mucocutaneous swab specimens.
Includes | Package insert, Dilution buffer, Lysis buffer, Reaction tubes; Lyophilized Master Mix reagent |
---|---|
Content And Storage | 2°C to 8°C (No ice or cooling block required) |
Type | Solana HSV 1+2/VZV Starter Kit |
Sensitivity | Cutaneous: 100% (HSV-1), 92.3% (HSV-2), 100% (VZV); Mucocutaneous: 100% (HSV-1), 99.1% (HSV-2), 100% (VZV); Non categorized: 100% (HSV-1), 100% (HSV-2), 100% (VZV) |
Sample Type | Cutaneous or mucocutaneous lesion samples obtained from symptomatic patients |
Shelf Life | Up to 12 Months from DOM |
For Use With (Application) | Diagnosis of Herpes Simplex Virus (HSV) 1 and 2 and Varicella-zoster virus (VZV) |
Clia Complexity | Moderate - Prescription Use Only |
Test Time | ≈50 min. |
For rapid differential diagnosis of acute influenza A and influenza B viral infections
For use with Quidel CARDS Q.S. hCG and QuickVue™ Semi-Q hCG Combo Tests
Built-in controls satisfy CLIA requirements for daily QC
Aids in the rapid differential diagnosis of acute influenza A and B virus infection